Key statistics
On Monday, CareDx Inc (1K9:FRA) closed at 15.55, -26.29% below its 52-week high of 21.09, set on Mar 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.55 |
|---|---|
| High | 15.55 |
| Low | 15.55 |
| Bid | -- |
| Offer | -- |
| Previous close | 15.72 |
| Average volume | 25.40 |
|---|---|
| Shares outstanding | 51.22m |
| Free float | 49.05m |
| P/E (TTM) | -- |
| Market cap | 960.82m USD |
| EPS (TTM) | -0.3943 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:14 GMT.
More ▼
Press releases
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
- CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
- CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
- CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
- CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
- CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
- CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
More ▼
